CERS
CERUS CORP
NASDAQ · Healthcare · Medical - Devices · US
$2.65
−0.38%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.01
- Revenue estimate
- $63.3M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$0.01
- EPS estimate
- -$0.01
- Revenue actual
- $63.3M
- Revenue estimate
- $62.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +52.8%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.01 | -$0.01 | Beat 24.98% | $63.3M |
| Apr 30, 2026 | -$0.03 | -$0.01 | Beat 66.67% | $59.9M |
| Nov 6, 2025 | -$0.02 | -$0.00 | Beat 99.50% | $52.7M |
| May 1, 2025 | -$0.05 | -$0.04 | Beat 20.00% | $43.2M |
| Feb 20, 2025 | -$0.01 | -$0.01 | In line | $50.8M |
| Aug 1, 2024 | -$0.02 | -$0.03 | Miss -25.00% | $45.1M |
| May 2, 2024 | -$0.05 | -$0.05 | Miss -7.14% | $38.4M |
| Mar 5, 2024 | -$0.01 | -$0.01 | Miss -58.23% | $46.8M |
| Nov 2, 2023 | -$0.05 | -$0.03 | Beat 40.00% | $39.8M |
| Aug 2, 2023 | -$0.05 | -$0.07 | Miss -40.00% | $38.9M |
| May 4, 2023 | -$0.05 | -$0.09 | Miss -80.00% | $31.0M |
| Feb 28, 2023 | -$0.05 | -$0.08 | Miss -68.42% | $44.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026